The Association Between Event-Free Survival And Pathological Complete Response To Neoadjuvant Lapatinib, Trastuzumab Or Their Combination In Her2-Positive Breast Cancer. Survival Follow-Up Analysis Of The Neoaltto Study (Big 1-06)
CANCER RESEARCH（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要